India Pharma Outlook Team | Monday, 11 March 2024
Apollo Hospitals Group, India’s largest integrated healthcare provider, recently unveiled the ZAP-X gyroscopic radiosurgery platform, a revolutionary advancement in brain tumor treatment, marking a significant milestone as the first in South Asia to introduce this ground-breaking technology. With ZAP-X, Apollo Hospitals continues its legacy of innovation and commitment to providing world-class healthcare solutions for patients in India and worldwide.
ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes.
This transformative technology redefines precision with minimal radiation exposure, enabling new effectiveness and patient comfort standards. Unlike conventional methods, ZAP-X utilizes a self-shielded, gyroscopic linear accelerator design to direct radiosurgical beams from thousands of potential angles, accurately focusing radiation on the intended tumor or target.
This innovative method improves patient outcomes by enhancing the ability to avoid critical structures like the brain stem, eyes, and optic nerves while also drastically minimizing exposure to healthy brain tissue to safeguard a patient’s cognitive function.
ZAP-X’s proven clinical capabilities will enable neurologists and neurosurgeons to treat primary and metastatic brain tumors, arteriovenous malformations (AVMs), trigeminal neuralgias, movement disorders such as Parkinson’s disease, epilepsy and other intracranial lesions such as meningiomas, acoustic neuromas, and pituitary adenomas, with better accuracy and fewer side effects to patients.
Dr Prathap Chandra Reddy, founder chairman of Apollo Hospitals Group, said at the launch: “For more than four decades, Apollo Hospitals has been at the forefront of healthcare, continuously challenging limits to provide exceptional care. Continuing this process, we discovered ZAP-X, a new technology for treating brain tumors.
, CDSCO.jpg)
.jpg)